Mucoepidermoid carcinoma of salivary gland

Epidemiology

The most common malignant tumour of salivary glands, it constitutes 15.5% of all salivary gland tumours and 29% of all malignancies, occurring in both major and minor salivary glands2.

Histopathology

Mucoepidermoid carcinomas are composed of varying proportions of epidermoid, glandular, mucous and intermediate cells.

Immunohistochemistry

cytokeratin 7

20/202

cytokeratin 8/18

28/282

cytokeratin 14

28/282

cytokeratin 17

8/82

cytokeratin 19

28/282

MUC1

20/204, 44/623

MUC2

13/633

MUC4

48/613

MUC5AC

13/194, 43/633

     
     
     

Differential diagnosis

High grade mucoepidermoid carcinoma:

Prognosis

There is a broad spectrum of aggressiveness. Outcome is dependent on tumour grade, margin status, location of the tumour and nodal status2. Negativity for MUC1 may be associated with a better prognosis3.

References

1 Chu, P. G. and L. M. Weiss (2002). "Keratin expression in human tissues and neoplasms." Histopathology 40(5): 403-39. (Summary data from multiple papers)

2 Perez-Ordonez B. Selected topics in salivary gland tumour pathology. Current Diagnostic Pathology2003;9:355-365.

3 Handra-Luca A, Lamas G, Bertrand JC, et al. MUC1, MUC2, MUC4, and MUC5AC expression in salivary gland mucoepidermoid carcinoma: diagnostic and prognostic implications. Am J Surg Pathol 2005; 29:881-9

4 Alos L, Lujan B, Castillo M. Expression of mucins (MUC1, MUC2, MUC5AC, MUC6) in mucoepidermoid carcinoma of salivary glands. Modern Pathology 2004;17:926 (abstract)

This page last revised 11.9.2005.

©SMUHT/PW Bishop